IPO
Recent changes
- Aug 25, 2026Aug 25, 2026Two More S-1s Land: Enhanced Group, Serina Therapeutics Pulse story
- Aug 24, 2026Aug 24, 2026Serina Therapeutics Files to Sell Shares for Parkinson's Drug Pulse story
Latest Pulse
- Aug 25, 2026Two More S-1s Land: Enhanced Group, Serina TherapeuticsEnhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.→
- Aug 24, 2026Serina Therapeutics Files to Sell Shares for Parkinson's DrugBiotech Serina Therapeutics filed an S-1 covering up to 12.5 million shares tied to a stock purchase agreement, funding continued development of its lead Parkinson's disease candidate SER-252 built on its POZ drug-delivery platform.→
Coverage Timeline
newest firstAll Coverage
IPO
Two More S-1s Land: Enhanced Group, Serina Therapeutics
Enhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.
BY THE NUMBERS
IPO
Serina Therapeutics Files to Sell Shares for Parkinson's Drug
IPO
Serina Therapeutics Files to Sell Shares for Parkinson's Drug
Biotech Serina Therapeutics filed an S-1 covering up to 12.5 million shares tied to a stock purchase agreement, funding continued development of its lead Parkinson's disease candidate SER-252 built on its POZ drug-delivery platform.
DEEP DIVE